T0	Participants 58 183	patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
T1	Participants 334 386	patients receiving dual antiplatelet therapy (DAPT).
T2	Participants 834 897	DM patients with stable coronary artery disease receiving DAPT.
T3	Participants 1389 1400	40 patients
T4	Participants 2107 2163	DM patients with coronary artery disease receiving DAPT.